In a filing, Nuvectis Pharma Inc revealed its Vice President, Finance Carson Michael J. unloaded Company’s shares for reported $22478.0 on Nov 07 ’24. In the deal valued at $8.16 per share,2,755 shares were sold. As a result of this transaction, Carson Michael J. now holds 87,918 shares worth roughly $0.95 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BENTSUR RON bought 1,940 shares, generating $13,076 in total proceeds. Upon buying the shares at $6.74, the Chairman & CEO now owns 3,246,424 shares.
Before that, BENTSUR RON bought 2,000 shares. Nuvectis Pharma Inc shares valued at $12,800 were divested by the Chairman & CEO at a price of $6.40 per share. As a result of the transaction, BENTSUR RON now holds 3,244,484 shares, worth roughly $35.07 million.
Ladenburg Thalmann initiated its Nuvectis Pharma Inc [NVCT] rating to a Buy in a research note published on July 13, 2022; the price target was $21.
Price Performance Review of NVCT
On Monday, Nuvectis Pharma Inc [NASDAQ:NVCT] saw its stock unchanged to $10.81. Over the last five days, the stock has gained 71.32%. Nuvectis Pharma Inc shares have risen nearly 29.62% since the year began. Nevertheless, the stocks have risen 31.35% over the past one year. While a 52-week high of $12.10 was reached on 03/14/24, a 52-week low of $5.85 was recorded on 08/05/24. SMA at 50 days reached $7.00, while 200 days put it at $7.19.
Levels Of Support And Resistance For NVCT Stock
The 24-hour chart illustrates a support level at 9.62, which if violated will result in even more drops to 8.42. On the upside, there is a resistance level at 11.75. A further resistance level may holdings at 12.68. The Relative Strength Index (RSI) on the 14-day chart is 75.05, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.75, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 12.39%. Stochastics %K at 87.95% indicates the stock is a selling.
How much short interest is there in Nuvectis Pharma Inc?
A steep rise in short interest was recorded in Nuvectis Pharma Inc stocks on 2024-10-15, growing by 69769.0 shares to a total of 1.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 0.98 million shares. There was a rise of 6.66%, which implies that there is a positive sentiment for the stock.
